A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
Condition(s):Cervical Cancer; Genital Wart; CIN1; CIN2; CIN3; Vain I; Vain III; Vin I; Vin II; Vin III; AIS; VAIN – Vaginal Intraepithelial Neoplasia 2Last Updated:July 21, 2023Terminated